Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Thomas, Michael [1 ]
Sadjadian, Parvis [2 ]
Kollmeier, Jens [3 ]
Hao, Zhonglin [4 ]
Patchen, Myra [5 ]
Lowe, Jamie [5 ]
Mattson, Paulette [5 ]
Huhn, Richard D. [5 ]
Bose, Nandita [5 ]
Antonysamy, Mary [5 ]
Gargano, Michele [5 ]
Gordon, Keith [5 ]
Schneller, Folker [6 ]
机构：
[1] Univ Clin Heidelberg, Heidelberg, Germany
[2] Johannes Wesling Klinikum Minden, Minden, Germany
[3] Helios Clin Emil von Behring, Berlin, Germany
[4] Georgia Hlth Sci Univ, Augusta, GA USA
[5] Biothera Inc, Eagan, MN USA
[6] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
来源：
CLINICAL CANCER RESEARCH | 2014年 / 20卷
关键词：
D O I：
10.1158/1078-0432.14AACRIASLC-A26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A26
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer
    Choy, H
    Akerley, W
    DeVore, RF
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 36 - 43
  • [42] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [43] A randomized comparison of carboplatin/vinorelbine versus carboplatin/gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Helbekkmo, N.
    Sundtroem, S. H.
    Aaseboe, U.
    Brunsvig, P. F.
    Von Plessen, C. L.
    Bremnes, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 372S - 372S
  • [44] Biweekly combination chemotherapy with paclitaxel and carboplatin for advanced non-small cell lung cancer.
    Takayama, K
    Ichiki, M
    Kawasaki, M
    Ninomiya, K
    Miyazaki, N
    Kuba, M
    Iwami, F
    Nakanishi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 699S - 699S
  • [45] Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)
    Langer, CJ
    McAleer, CA
    Bonjo, CA
    Litwin, S
    Millenson, M
    Kosierowski, R
    Blankstein, K
    Alexander, R
    Ozols, RF
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (02) : 183 - 193
  • [46] Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer
    Langer, CJ
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (02) : 108 - 116
  • [47] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [48] Gemcitabine-paclitaxel-carboplatin (PCG) versus paclitaxel-carboplatin (PC) in advanced non-small cell lung cancer (NSCLC): Quality of life (QOL) analysis
    Oniga, F.
    Paccagnella, A.
    Luise, A.
    Biason, R.
    Ghi, M. G.
    Gatti, C.
    Nascimben, O.
    Mastromauro, C.
    Medici, M.
    D'Amanzo, P.
    Carnuccio, R.
    McMahon, L.
    ANNALS OF ONCOLOGY, 2006, 17 : XI19 - XI19
  • [49] Carboplatin and paclitaxel in non-small cell lung cancer: The role of amifostine
    Selvaggi, G
    Belani, CP
    SEMINARS IN ONCOLOGY, 1999, 26 (02) : 51 - 60
  • [50] Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer
    Vokes, EE
    Mauer, AM
    Hoffman, PC
    Masters, G
    Watson, S
    Golomb, HM
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 76 - 76
12345